Trilaciclib trials for Lung cancer

All Trilaciclib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Trilaciclib for Lung cancer

• Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
  NCT07473128 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
  NCT06698965 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Trilaciclib and Lurbinectidin
  NCT05578326 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan
  NCT05874401 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Trilaciclib for Lung cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.